A New Vision for Diabetes
Sponsored by Allergan
Diabetes-related eye disease is now one of the leading causes of blindness among working-age adults globally. On November 14, 2019, our forum, A New Vision for Diabetes, sought to bring together both ophthalmologists and diabetologists to discuss the need for an integrated approach to diabetes management.
Chaired by John Marshall, Professor of Ophthalmology at the UCL Institute of Ophthalmology, the panel kicked off with the challenges facing healthcare professionals. The discussion then moved on to issues related to current standard of care and how new trends, such as telemedicine and virtual clinics, can help overcome current challenges.
Find out what the panelists had to say about diabetes-related eye disease by watching the video today. Why should you watch?
- To find out how to establish an open, honest discourse between ophthalmologists and diabetologists
- To unravel the current standards of care for patients with diabetic eye disease, and the issues facing HCPs worldwide
- To understand how to plan for a more integrated, holistic approach to patient and disease management
- To earn 2 hours’ worth of CPD points
Panel
Interviews
John Marshall on the latest innovations in the management of diabetic eye disease
John Marshall, Professor of Ophthalmology at UCL, predicts the biggest issues for diabetes management in the coming years, and discusses the latest innovations and trends in detecting, diagnosing and treating diabetic eye disease.
Ralph Abraham, on educating patients with diabetes, and improving their outcomes
Ralph Abraham, Consultant in Diabetes, Endocrinology and Lipid Disorders and founder of the London Diabetes Center, highlights the importance of educating patients on diabetes prevention and discusses how his own work aims to improve patient outcomes. He also tells us what he thinks ophthalmologists need to know about diabetes management.
Winfried Amoaku on the diabetologist’s role in treating diabetic eye disease
Winfried Amoaku, Clinical Associate Professor of Ophthalmology and Visual Sciences at Nottingham University, discusses the biggest issues associated with diabetic eye disease, the role a diabetologist plays in ongoing treatments, and the current best practice for treating DME.
Shazli Azmi on making the future brighter for patients with diabetes
Shazli Azmi, Consultant in Diabetes and Endocrinology at Manchester University Foundation Trust, describes how microvascular changes can affect diabetic eye disease, talks about the biggest barriers to early intervention in diabetes management, and explains how we can make the future brighter for patients.
Dawn Sim on the use of telemedicine and virtual clinics for patients with diabetic eye disease
Dawn Sim, Director of Telemedicine and Consultant Ophthalmologist in Medical Retina and Cataract Surgery at Moorfields Eye Hospital, shares her thoughts on telemedicine, virtual clinics and other key factors that could help make the future better for patients suffering from diabetic eye disease.
